C12N 2501/17
Angiopoietin
C12N2501/17 (Angiopoietin) appears on 39 US grants and 61 published applications in this corpus.
Search patents in C12N- Granted patents
- 39
- Published applications
- 61
- Assignees
- 29
- Inventors
- 70
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 2 | 0 |
| 2011 | 2 | 5 |
| 2012 | 0 | 1 |
| 2013 | 2 | 1 |
| 2014 | 2 | 4 |
| 2015 | 0 | 2 |
| 2016 | 4 | 4 |
| 2017 | 2 | 7 |
| 2018 | 2 | 3 |
| 2019 | 4 | 5 |
| 2020 | 4 | 8 |
| 2021 | 3 | 5 |
| 2022 | 2 | 5 |
| 2023 | 5 | 1 |
| 2024 | 0 | 1 |
| 2025 | 3 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of inducing or improving wound healing properties of mesenchymal stem cells4 Nov 2025US 12,460,178 B2Cellresearch Corporation Pte. Ltd.
- Lyophilized compositions containing umbilical cord lining stem cells conditioned medium4 Nov 2025US 12,460,179 B2Restem LLC
- Method of autologous primary hair follicles preparation in 3D culture25 Feb 2025US 12,234,478 B2Reelabs Pvt. Ltd.
- Stem cell-derived skin precursor cell culture medium and preparation method therefor3 Oct 2023US 11,773,370 B2Cha Biotech Co., Ltd.
- Q-peptide hydrogel promotes immune modulation and macrophage differentiation26 Sep 2023US 11,766,469 B2Quthero, Inc.
- Method of inducing or improving wound healing properties of mesenchymal stem cells4 Jun 2026US 2026/0152717 A1Cellresearch Corporation Pte. Ltd.
- Methods for producing red blood cells11 Sep 2025US 2025/0283041 A1Albert Einstein College of Medicine
- Method of using factor rich product from umbilical cord mesenchymal stem cells to increase collagen and elastin in human skin17 Jul 2025US 2025/0230404 A1
- Regeneration of a Functional Pulmonary Vascular Bed7 Nov 2024US 2024/0368562 A1The General Hospital Corporation
- Pd-l1 expressing hematopoietic stem cells and uses12 Oct 2023US 2023/0321150 A1Children's Medical Center Corporation
Most cited
By later US patents
- Tie2 antagonist antibodies39US 6,376,653 B1SmithKline Beecham Corporation · 2002
- Methods for expansion and analysis of cultured hematopoietic stem cells21US 7,807,464 B2Whitehead Institute for Biomedical Research · 2010
- Keratinocytes expressing exogenous angiogenic growth factors9US 7,498,167 B22009
- Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a9US 7,807,148 B2Stratatech Corporation · 2010
- Peptides and compositions for treatment of joint damage7US 9,868,771 B2Novartis AG · 2018